Empagliflozin versus Sitagliptin as add-on dual therapy in Egyptian patients with type 2 diabetes inadequately controlled with Metformin: a 12-week randomized, open-label, parallel-group trial (vol 12, 104, 2023)

被引：0
|
作者：
Zakaraia, Haitham G. [1 ]
Salem, Heba F. [2 ]
Mostafa, Mostafa A. A. [3 ]
Ali, Ahmed M. [4 ]
Rabea, Hoda M. [5 ]
机构：
[1] Univ Sadat City, Fac Pharm, Clin Pharm Dept, POB 32897, Sadat City, Menoufia, Egypt
[2] Beni Suef Univ, Fac Pharm, Pharmaceut & Ind Pharm Dept, POB 62514, Bani Suwayf, Egypt
[3] October 6 Univ, Fac Med, Internal Med Dept, POB 12585, Giza, Egypt
[4] October 6 Univ, Fac Pharm, Clin Pharm Dept, POB 12585, Giza, Egypt
[5] Beni Suef Univ, Fac Pharm, Clin Pharm Dept, POB 62514, Bani Suwayf, Egypt
来源：
BENI-SUEF UNIVERSITY JOURNAL OF BASIC AND APPLIED SCIENCES | 2024年 / 13卷 / 01期
关键词：
D O I：
10.1186/s43088-024-00487-9
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Pancreatic Effects of Liraglutide or Sitagliptin in Overweight Patients With Type 2 Diabetes: A 12-Week Randomized, Placebo-Controlled Trial
    Smits, Mark M.
    Tonneijck, Lennart
    Muskiet, Marcel H. A.
    Kramer, Mark H. H.
    Pieters-van den Bos, Indra C.
    Vendrik, Karuna E. W.
    Hoekstra, Trynke
    Bruno, Marco J.
    Diamant, Michaela
    van Raalte, Daniel H.
    Cahen, Djuna L.
    DIABETES CARE, 2017, 40 (03) : 301 - 308
  • [22] Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial. (vol 375, pg 1447, 2010)
    Pratley, R. E.
    Nauck, M.
    Bailey, T.
    LANCET, 2010, 376 (9737): : 234 - 234
  • [23] Metformin Treatment in Type 2 Diabetes in Pregnancy: An Active Controlled, Parallel-Group, Randomized, Open Label Study in Patients with Type 2 Diabetes in Pregnancy
    Ainuddin, Jahan Ara
    Karim, Nasim
    Zaheer, Sidra
    Ali, Syed Sanwer
    Hasan, Anjum Ara
    JOURNAL OF DIABETES RESEARCH, 2015, 2015
  • [24] Closed-Loop Insulin Therapy for People With Type 2 Diabetes Treated With an Insulin Pump: A 12-Week Multicenter, Open-Label Randomized, Controlled, Crossover Trial
    Borel, Anne-Laure
    Lablanche, Sandrine
    Waterlot, Christine
    Joffray, Eloise
    Barra, Celine
    Arnol, Nathalie
    Amougay, Hafid
    Benhamou, Pierre-Yves
    DIABETES CARE, 2024, 47 (10) : 1778 - 1786
  • [25] Empagliflozin (EMPA) as add-on to linagliptin (LINA) and metformin in patients with type 2 diabetes (T2DM): a 24-week randomised, double-blind, parallel-group trial
    Maldonado-Lutomirsky, M.
    Softeland, E.
    Meier, J. J.
    Vangen, B.
    Toorawa, R.
    Woerle, H. -J.
    Broedl, U. C.
    DIABETOLOGIA, 2016, 59 : S93 - S93
  • [26] Empagliflozin (EMPA) as Add-on to Linagliptin (LINA) and Metformin in Patients with Type 2 Diabetes (T2DM): A 24-Week Randomized, Double-Blind, Double-Dummy, Parallel-Group Trial
    Softeland, Eirik
    Meier, Juris J.
    Vangen, Bente
    Toorawa, Robert
    Maldonado, Mario
    Woerle, Hans J.
    Broedl, Uli C.
    DIABETES, 2016, 65 : A295 - A295
  • [27] Impact of a 12-week open-label placebo treatment on headache days in episodic and chronic migraine: a study protocol for a parallel-group, multicentre, randomised controlled trial
    Schmidt, Katharina
    Kleine-Borgmann, Julian
    Holle-Lee, Dagny
    Gaul, Charly
    Bingel, Ulrike
    BMJ OPEN, 2021, 11 (06):
  • [28] Effects of replacing metformin with pioglitazone on glycemic control in Japanese patients with poorly controlled type 2 diabetes mellitus: A 12-week, open-label, prospective study
    Sakaue, Shinji
    Kamigaki, Mitsunori
    Yoshimura, Haruhiko
    Nishimura, Masaharu
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2008, 69 (04): : 364 - 377
  • [29] Henagliflozin as add-on therapy to metformin in patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double-blind, placebo-controlled, phase 3 trial
    Weng, Jianping
    Zeng, Longyi
    Zhang, Yuwei
    Qu, Shen
    Wang, Xueying
    Li, Ping
    Fu, Liujun
    Ma, Boqing
    Ye, Shandong
    Sun, Jiao
    Lu, Weiping
    Liu, Zhiwen
    Chen, Daoxiong
    Cheng, Zhifeng
    Liu, Haiyan
    Zhang, Tao
    Zou, Jianjun
    DIABETES OBESITY & METABOLISM, 2021, 23 (08): : 1754 - 1764
  • [30] Pioglitazone as Add-on Therapy in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Dapagliflozin and Metformin: Double-Blind, Randomized, Placebo-Controlled Trial
    Heo, Ji Hye
    Han, Kyung Ah
    Hong, Jun Hwa
    Seo, Hyun-Ae
    Hong, Eun-Gyoung
    Yu, Jae Myung
    Jung, Hye Seung
    Cha, Bong-Soo
    DIABETES & METABOLISM JOURNAL, 2024, 48 (05)
12345